Ed Arce

Stock Analyst at HC Wainwright & Co.

(1.53)
# 1622
Out of 5,380 analysts
598
Total ratings
Success rate
Average return
57 Stocks
Name Action PT Current % Upside Ratings Updated
TVTX Travere Therapeutics
Assumes: Buy
30
15.18 97.63% 21 Jun 11, 2025
MTVA MetaVia
Reiterates: Buy
12 12
0.68 1664.71% 3 Apr 16, 2025
UNCY Unicycive Therapeuti...
Reiterates: Buy
75 75
6.92 983.82% 27 Apr 11, 2025
ARCT Arcturus Therapeutic...
Reiterates: Buy
60 60
13.44 346.43% 31 Apr 10, 2025
AKBA Akebia Therapeutics
Reiterates: Buy
8 8
3.67 104.36% 36 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
3.15 312.7% 16 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 17 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
n/a n/a 6 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
8.32 741.35% 6 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 13 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 8 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
0.62 1835.48% 17 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 24 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32
9.81 226.2% 11 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
24 35
46.58 -24.86% 22 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 75
53.8 39.41% 25 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 21
9.79 114.5% 22 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 72
51.12 40.85% 30 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
400 405
285.04 42.09% 17 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
6 6
3.67 49.86% 9 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
95 95
37.12 155.93% 6 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
7.38 143.9% 11 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
3.82 240.31% 18 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.39 47.49% 18 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48 48
18.46 160.02% 2 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8 8
3.83 95.82% 11 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.98 410.2% 13 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
8.05 61.49% 16 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
12 240
0.66 36263.64% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 8 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
33
n/a n/a 20 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
22.56 10.82% 8 Dec 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 8 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
3
n/a n/a 12 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
40
n/a n/a 4 Jun 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 5 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
42
n/a n/a 10 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 69
n/a n/a 1 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6 2
n/a n/a 4 Mar 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 39
n/a n/a 8 Nov 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13500 14625
n/a n/a 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1750 0
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 12, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
2188
n/a n/a 4 May 31, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 15
n/a n/a 3 Mar 22, 2019